Other Resources

Education Tools

Immunize Canada's new HPV poster

Activity plan:  Health promotion - Human Papillomavirus

HPV Powerpoint Presentation

STI Flipchart

HPV Multilingual Chart 

Scientific Articles / Reports

OB-Gyn News - Article on HPV testing - July 2011

National Advisory Committee on Immunization (NACI) Statement on Human Papillomavirus Vaccine

The National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada with ongoing medical, scientific and public health advice relating to immunization.  This comprehensive statement on the HPV vaccine was published in February 2007.

Canadian Human Papillomavirus Vaccine Research Priorities Workshop

53 Canadian and international HPV experts and researchers met with academia, public health and industry leaders to examine the status of the HPV vaccine in November 2005.

ACOG recommends initial OB GYN visit at ages 13-15: Committee opinion outlines topics, coding

The American College of Obstetricians and Gynecologists that health-care practitioners educate young women aged 13-15 on STIs, menses, sexual orientation, healthy eating and prevention of pregnancy.

Are women ready for the HPV vaccine?

Get the results from the study that asked women if they would consent to the HPV vaccination themselves, anad for their children.  Conducted by the Department of Gynecologic Oncology (University of Texas) and the Anderson Cancer Center (Houston).

Carcinogenicity of Human papillomavirus

Scientists from 13 countries met at the International Agency for Research on Cancer to reassess the carcinogenicity of human papillomaviruses.

The epidemiology of Human papillomaviruses

Explores HPV prevention, estimates of disease frequency, and risk factors for HPV infection.  Also discusses the natural history of HPV infection, including viral persistence versus clearance, immune response, development of lesions and development of cancer.

 

Links

Canadian Association of Provincial Cancer Agencies (CAPCA)

CAPCA is an interprovincial organization representing provincial/territorial cancer agencies and programs engaged in cancer control.

Canadian Organization of Medical Physicists

Directory of medical physicists, whose work varies from hospital diagnostic imaging departments to cancer treatment facilities to hospital-based research.

Canadian Oncology Societies

Founded in 1976, the COS supports public cancer education programs

Women's Cancer Network

The WCN helps women living with cancer and their families, understand the disease and gain access to new or experimental therapies.

Protecting against HPV and Related Cancers
(in English only/en anglais seulement)

In this video produced by Canadaian Health and Family, Dr. Durand shares options to help protect against and prevent HPV and its related diseases. 

"Should you get the HPV Vaccine?"
(in English only/en anglais seulement)

In this animated 9 minute video, Dr. Mike Evans explores the question "Should you get the HPV Vaccine?" 

Public Health Agency of Canada

Centre for Chronic Disease Prevention and Control (CCDPC)

CCDPC Cervical Cancer Program

CCDPC Cervical Cancer Screening Guidelines

Canadian Guidelines on Sexually Transmitted Infections 2010 Edition

Canadian Strategy for Cancer Control

 

Guidelines Advisory Committee (Ontario)

Advancing the use of evidence-based Clinical Practice Guidelines

 

Cervical Cancer guidelines (specifically)

Institute for Clinical Systems Improvement: Cervical Cytology (Pap Smear) and HPV Testing, Initial Management of Abnormal (guideline) 

FAQ

img5.jpg

Types 16 and 18 of HPV are considered "high risk" because they can cause cancer and are responsible for 25% of CIN 1 lesions and 70% of CIN 2 and 3 lesions, and anogenital cancers. "Low risk" types 6 and 11 generally do not cause cancer but are associated with 25% of CIN 1 lesions and 90% of genital and anal warts.